Your session is about to expire
← Back to Search
HIPEC + IV Chemotherapy for Ovarian Cancer
Study Summary
This trial will test if treating ovarian cancer with Heated Intraperitoneal Chemotherapy (HIPEC) followed by intravenous (IV) chemotherapy can start within 42 days of HIPEC.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My blood counts and liver/kidney functions are within normal ranges.I haven't had chemotherapy or radiotherapy in the last 4 weeks or I'm still recovering from their side effects.I have cancer that has spread beyond my abdomen.I do not have and have never had inflammatory bowel disease.I am scheduled for surgery to remove as much of the cancer as possible.I am 18 years old or older.I have ovarian, fallopian tube, or peritoneal cancer at Stage 3B-3C with minimal remaining disease.My cancer is one of the specified types of epithelial cell cancer.I have never had HIPEC treatment.I can take care of myself and am up and about more than half of the day.I do not have any serious ongoing illnesses like heart problems or infections.I do not have a borderline ovarian tumor or recurrent ovarian cancer treated with surgery only.I am not pregnant or nursing.I have never had, or my past endometrial cancer was early stage and not aggressive.You have had allergic reactions to drugs similar to Cisplatin, carboplatin, or paclitaxel.I need considerable assistance and can't do any physical work.
- Group 1: HIPEC + adjuvant IV chemotherapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the enrollment period for this research study currently accessible to participants?
"As of today, this medical study is still recruiting participants. It was initially published on December 15th 2017 and the latest update to its page occurred on January 21st 2022."
How many individuals are being enrolled in this clinical experiment?
"Correct, according to records on clinicaltrials.gov this study is actively recruiting participants. It was first posted in December 2017 and most recently updated in January 2022 with the aim of enrolling 20 people at one site."
Has the use of HIPEC been examined in other research efforts?
"Presently, 1174 investigations into HIPEC are underway with 332 in their final phase. Of these trials, the majority originate from Shanghai; however, there exist 66513 different sites where such studies may be conducted."
Has the FDA given clearance to use HIPEC?
"HIPEC's safety has been largely corroborated in Phase 2 clinical trials, so it was rated a 2."
Share this study with friends
Copy Link
Messenger